Por favor, use este identificador para citar o enlazar este ítem:
|Título :||Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus : an observational, cross-sectional, multicenter study in Spain from the risk-systemic lupus erythematosus thematic network.|
|Autor :||Fernández Garcés, María del Mar.|
Haro Cortés, Gonzalo Rafael.
Micó Giner, María Luisa.
|Materias:||Enfermedades cardiovasculares en las mujeres - Factores de riesgo.; Cardiovascular system - Diseases in women - Risk factors.; Lupus eritematoso - Tratamiento.; Hipertensión - Farmacoterapia.; Hypertension - Chemotherapy.; Lupus erythematosus - Treatment.|
|Fecha de publicación :||1-oct-2019|
|Editorial :||Lippincott Williams & Wilkins.|
|Citación :||Fernández-Garcés, M., Haro, G. & Micó, ML. (2019). Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus : an observational, cross-sectional, multicenter study in Spain from the risk-systemic lupus erythematosus thematic network. Medicine, vol. 98, n. 43, art. e17489 (oct.). DOI: https://doi.org/10.1097/MD.0000000000017489|
|Resumen :||Very few studies have been published on cardiovascular morbidity in Spanish patients diagnosed with systemic lupus erythematosus (SLE). Moreover, knowledge of the predictive factors for the occurrence of nonfatal events in this group of patients is scarce. This was a multicenter, observational, cross-sectional study designed to ascertain the prevalence of nonfatal cardiovascular risk factors and cardiovascular events (CVEs) in 335 Spanish women diagnosed with SLE between 2003 and 2013. The average patient age was 36.0 years (range: 26.4–45.6); 35 patients (10.7%) experienced at least 1 CVE, which most frequently affected the brain, followed by the heart, and finally, the peripheral vasculature. Both the number of admissions because of SLE (95% confidence interval [CI] odds ratio [OR]=1.024–1.27, P=.017) and the systemic lupus international collaborating clinics (SLICC) chronicity index score (95% CI OR=1.479–2.400, P=.000) resulted in an increase in the OR of these patients presenting a CVE. Regarding the classic risk factors, only the interaction between hypertension (HT) and treatment with antihypertensive drugs influenced the presence of CVEs (95% CI OR=2.165–10.377, P=.000). The presence of a family history of early cardiovascular disease was also related to CVEs (95% CI OR=2.355–40.544, P=.002). Binary logistic regression including the above factors resulted in a model in which the 3 main variables in each group persisted, implying that they must be independent of each other. However, the weight of the interaction between the family history of early cardiovascular disease and the interaction between HT and the use of antihypertensives was higher than for the number of admissions for SLE. The SLE disease activity over time (measured using the SLICC) and the number of hospital admissions due to the disease itself, both increase the risk of women with SLE presenting a CVE. Classic cardiovascular risk factors, especially HT and its treatment, as well as a family history of early CVEs, should be considered when assessing the risk of nonfatal CVEs in women with SLE.|
|Descripción :||Este es el artículo que se ha publicado de forma definitiva en: https://journals.lww.com/md-journal/Fulltext/2019/10250/Predisposing_factors_to_nonfatal_cardiovascular.19.aspx|
|Aparece en las colecciones:||Dpto. Medicina y Cirugía|
Ficheros en este ítem:
|Predisposing_Fernandez_Medicine_2019.pdf||433,55 kB||Adobe PDF||Visualizar/Abrir|
Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.